Interacting Drugs |
Trabectedin vs HMG-CoA Reductase Inhibitors |
Security Level |
|
Mechanism |
HMG-CoA Reductase Inhibitors: May enhance the myopathic (rhabdomyolysis) effect of Trabectedin. |
Management |
Monitor therapy |
Trabectedin vs HMG-CoA Reductase Inhibitors
Post Review about Trabectedin vs HMG-CoA Reductase Inhibitors Click here to cancel reply.
Other Interactions of Trabectedin
Other Interactions of HMG-CoA Reductase Inhibitors
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.